The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: Single center experience
Özet
OBJECTIVES:: Multifocal/multicentric breast cancers have been comprehensively studied and their outcomes have been compared with unifocal tumors. We evaluated the impact of multifocality and multicentricity on the disease-free survival (DFS) and overall survival of breast cancer patients and tried to analyze the correlation between multifocality/multicentricity (M/M) and other prognostic factors. MATERIAL AND METHODS:: Between 1994 and 2009, we analyzed retrospectively 697 breast cancer patients. Multicentric and multifocal breast cancer were defined as the presence of 2 or more invasive tumor foci within the different quadrants of the same breast or within a same quadrant of the breast, respectively. M/M and other prognostic factors were evaluated using univariate and multivariate analyses. RESULTS:: Multifocal/multicentric tumors were seen in 107 (15.4%) of the 697 breast cancer patients. pT and pN stage were related with the presence of multifocal/multicentric tumors. As tumor size increased and the number of axillary lymph nodes metastasis increased, the incidence of M/M increased significantly (P=0.003 vs. P=0.02, respectively). Overall, the median DFS time of patients with multifocal/multicentric tumors was significantly worse than that of the unifocal tumors (55 vs. 137 mo, P<0.001). Multivariate analysis showed that the presence of M/M was the most important prognostic factor for DFS (P=0.001, hazard ratio (HR): 0.33; 95% confidence interval (CI), 0.18-0.58), as were pN stage and extracapsular extension of the tumor (P=0.01, HR: 1.74; 95% CI, 1.13-2.69) (P=0.03, HR: 1.9; 95% CI, 1.04-3.47, respectively). M/M were not also statistically significant prognostic factors in breast cancer for overall survival (P=0.06). CONCLUSIONS:: M/M imparts an unfavorable prognosis on the DFS of breast cancer patients in comparison to unifocal tumors and the presence of multifocal/multicentric tumors were associated with advanced pT and pN stages.
Anahtar Kelimeler
- Scopus
- 36
- WoS
- 35
- OpenAlex
- 41
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Ustaalioglu, Basak Oven | |
| dc.contributor.author | Bilici, Ahmet | |
| dc.contributor.author | Kefeli, Umut | |
| dc.contributor.author | Şeker, Mesut | |
| dc.contributor.author | Oncel, Mustafa | |
| dc.contributor.author | Gezen, Cem | |
| dc.contributor.author | Gumus, Mahmut | |
| dc.contributor.author | Demirelli, Fuat | |
| dc.date.accessioned | 2026-10-22T10:20:57.132815020Z | |
| dc.date.available | 2026-10-22T10:20:57.132815020Z | |
| dc.date.issued | 2012 | |
| dc.description.abstract | OBJECTIVES:: Multifocal/multicentric breast cancers have been comprehensively studied and their outcomes have been compared with unifocal tumors. We evaluated the impact of multifocality and multicentricity on the disease-free survival (DFS) and overall survival of breast cancer patients and tried to analyze the correlation between multifocality/multicentricity (M/M) and other prognostic factors. MATERIAL AND METHODS:: Between 1994 and 2009, we analyzed retrospectively 697 breast cancer patients. Multicentric and multifocal breast cancer were defined as the presence of 2 or more invasive tumor foci within the different quadrants of the same breast or within a same quadrant of the breast, respectively. M/M and other prognostic factors were evaluated using univariate and multivariate analyses. RESULTS:: Multifocal/multicentric tumors were seen in 107 (15.4%) of the 697 breast cancer patients. pT and pN stage were related with the presence of multifocal/multicentric tumors. As tumor size increased and the number of axillary lymph nodes metastasis increased, the incidence of M/M increased significantly (P=0.003 vs. P=0.02, respectively). Overall, the median DFS time of patients with multifocal/multicentric tumors was significantly worse than that of the unifocal tumors (55 vs. 137 mo, P<0.001). Multivariate analysis showed that the presence of M/M was the most important prognostic factor for DFS (P=0.001, hazard ratio (HR): 0.33; 95% confidence interval (CI), 0.18-0.58), as were pN stage and extracapsular extension of the tumor (P=0.01, HR: 1.74; 95% CI, 1.13-2.69) (P=0.03, HR: 1.9; 95% CI, 1.04-3.47, respectively). M/M were not also statistically significant prognostic factors in breast cancer for overall survival (P=0.06). CONCLUSIONS:: M/M imparts an unfavorable prognosis on the DFS of breast cancer patients in comparison to unifocal tumors and the presence of multifocal/multicentric tumors were associated with advanced pT and pN stages. | |
| dc.identifier.doi | 10.1097/coc.0b013e31822d9cd6 | |
| dc.identifier.eissn | 1537-453X | |
| dc.identifier.endpage | 586 | |
| dc.identifier.issn | 1537-453X | |
| dc.identifier.issue | 6 | |
| dc.identifier.pmid | 21926901 | |
| dc.identifier.scopus | 2-s2.0-84870255249 | |
| dc.identifier.startpage | 580 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/gumushane/13120 | |
| dc.identifier.volume | 35 | |
| dc.identifier.wos | WOS:000311384000013 | |
| dc.language.iso | en | |
| dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | |
| dc.relation.ispartof | American Journal of Clinical Oncology: Cancer Clinical Trials | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | breast cancer | |
| dc.subject | disease-free survival | |
| dc.subject | multicentricity | |
| dc.subject | multifocality | |
| dc.subject.classification | Oncology | |
| dc.subject.other | Adult | |
| dc.subject.other | Aged | |
| dc.subject.other | Aged, 80 and over | |
| dc.subject.other | Axilla | |
| dc.subject.other | Breast Neoplasms | |
| dc.subject.other | Carcinoma, Ductal, Breast | |
| dc.subject.other | Carcinoma, Lobular | |
| dc.subject.other | Disease-Free Survival | |
| dc.subject.other | Female | |
| dc.subject.other | Humans | |
| dc.subject.other | Kaplan-Meier Estimate | |
| dc.subject.other | Lymphatic Metastasis | |
| dc.subject.other | Middle Aged | |
| dc.subject.other | Multivariate Analysis | |
| dc.subject.other | Neoplasm Staging | |
| dc.subject.other | Neoplasms, Multiple Primary | |
| dc.subject.other | Proportional Hazards Models | |
| dc.subject.other | Retrospective Studies | |
| dc.subject.other | Sentinel Lymph Node Biopsy | |
| dc.subject.other | Tumor Burden | |
| dc.subject.other | Young Adult | |
| dc.subject.other | anthracycline | |
| dc.subject.other | antineoplastic agent | |
| dc.subject.other | taxane derivative | |
| dc.subject.other | article | |
| dc.subject.other | axillary lymph node | |
| dc.subject.other | breast cancer | |
| dc.subject.other | breast carcinoma | |
| dc.subject.other | cancer adjuvant therapy | |
| dc.subject.other | cancer chemotherapy | |
| dc.subject.other | cancer incidence | |
| dc.subject.other | cancer invasion | |
| dc.subject.other | cancer localization | |
| dc.subject.other | cancer patient | |
| dc.subject.other | cancer prognosis | |
| dc.subject.other | cancer radiotherapy | |
| dc.subject.other | cancer size | |
| dc.subject.other | cancer staging | |
| dc.subject.other | cancer surgery | |
| dc.subject.other | cancer survival | |
| dc.subject.other | disease free survival | |
| dc.subject.other | disease severity | |
| dc.subject.other | human | |
| dc.subject.other | intraductal carcinoma | |
| dc.subject.other | lymph node dissection | |
| dc.subject.other | lymph node metastasis | |
| dc.subject.other | major clinical study | |
| dc.subject.other | mastectomy | |
| dc.subject.other | multiple cancer | |
| dc.subject.other | overall survival | |
| dc.subject.other | postmenopause | |
| dc.subject.other | premenopause | |
| dc.subject.other | retrospective study | |
| dc.title | The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: Single center experience | |
| dc.type | Article | |
| rdl.citation.openalex | 41 | |
| rdl.citation.scopus | 36 | |
| rdl.citation.wos | 35 | |
| rdl.oa.status | closed | |
| rdl.scopus.quartile | Q2 | |
| rdl.sdg | SDG03 | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |

